AAVivo, Inc. to Present at Society for Immunotherapy of Cancer 2025
AAVivo, Inc., a pioneering biotechnology company developing novel, precision targeted biotherapeutics to enable in vivo generation of CAR-T cells, today announced a presentation at the Society for Immunotherapy of Cancer 2025, which is being held November 5-9, in National Harbor, MD. https://mma.prnewswire.com/media/2767462/AAVivo_Logo.jpg AAVivo will present a poster titled, “In Vivo Generation of CD19-Specific CAR-T Cells […]